CLINICAL_TRIALS
trial_result
· 2026-03-09
Clinical Trial Update: Study of AK119 and AK112 With or Without Chemotherapy for NSCLC Patients [Phase 1, Phase 2]
Summary
A Phase 1/2 trial evaluating AK119 and AK112 with or without chemotherapy for non-small cell lung cancer has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Akeso | Conditions: NSCLC | Phase 1, Phase 2 | Status: TERMINATED